The Impact of Evolving Treatment Options in Multiple Myeloma, Part 5
November 15th 2021Joseph Mikhael, MD, reviews the phase 2 GRIFFIN trial evaluating the use of quadruplet therapy, daratumumab plus VRd, in patients with multiple myeloma, and the panel comments on the use of quadruplet therapy.
Read More
The Impact of Evolving Treatment Options in Multiple Myeloma, Part 2
November 1st 2021Ryan Haumschild, PharmD, MS, MBA, comments on the use of triplet regimens as the standard of care treatment for patients with multiple myeloma, and Thomas Ollis, MS, RPh, shares a community practice perspective.
Read More
Real-World Outcomes Among Patients With Early Rapidly Progressive Rheumatoid Arthritis
September 24th 2019This study suggests that lower healthcare resource use and achieving low disease activity are associated with first-line abatacept compared with a first-line tumor necrosis factor-α inhibitor for patients with early rapidly progressive rheumatoid arthritis.
Read More
The Gamification of Healthcare: Emergence of the Digital Practitioner?
January 16th 2019Gamification in healthcare is gaining momentum, with attempts to apply gaming principles to improve patient clinical outcomes. This trend establishes the need for a “digital practitioner” who channels these games, monitors progress, and selects the most appropriate ones for a given patient.
Read More
Can Clinical Pathways Change the 'Culture' in Cancer Care?
January 29th 2014Bruce A. Feinberg, DO, of Cardinal Health Specialty Solutions, published results in Evidence-Based Oncology1 showing that Cardinal's deployment of pathways had achieved measurable savings across a diverse set of healthcare providers, with an actuary's validation.
Read More